About 39 million people in the U.S. experience migraine headaches, but fewer than 30 percent have received a proper diagnosis and treatment.
Among the most common of all neurological disorders, migraine headaches affect one in five women in the U.S. and one in 16 men. The majority are not helped by current drugs.
Triptans, the newest class of migraine drugs on the market, work for only a third of those who take them, and many people cannot because of cardiovascular risks.
Due to side effects such as weight gain, hair loss, cognitive dysfunction and sedation, more than 85 percent of those who start treatment with preventative drugs stop taking them within a year.
There is a better solution! Click on the treatments above to learn how you can decrease or eliminate chronic vascular headaches, such as migraine, cluster and hypertensive headaches without shots or side effects of systemic drug use.